中文产业新闻评分62Chinese source
BioNTech BNT113 联合帕博利珠单抗头颈癌 2/3 期试验未达 PFS 主要终点
大瓜，mRNA+K药 vs K药头颈癌3期临床未达PFS终点
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
大瓜，mRNA+K药 vs K药头颈癌3期临床未达PFS终点
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.